Just look at this trial. They expect to enroll 96pt in a Alzheimers trial and have the trial wrap up by May 2013. Pretty ambitions for a trial that they just submitted.
Sentiment: Strong Buy
The market for Alzheimers is in the billions.
Great. ASTX could eventually be a 20 bagger.
Nice find. Always amazed on how much shorter the Phase's are for some non-oncology trials. The Hep C trials that I used to follow where always about 6 months or less in duration before results were revealed.